next generation glp-1 examples of glp 1 inhibitors receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease The GLP-1 revolution: What UAB

1 The weekly dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist integrates the action of both incretins into a single novel molecule, aiming to build upon the clinical benefits seen with a selective GLP-1 RA

"The most common mistake I see is people checking the mirror daily and getting discouraged in week two but that's exactly when nothing should be visible yet

PMID: 9089471 Jetton TL, et al

These symptoms often subside as your body adjusts to the medication

Lower levels of GHK-CU contribute to slower tissue repair, decreased collagen production, and reduced antioxidant protection

Clinical trials report average reductions of over 20% of body weight over 72 weeks